Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by Crazyfrog1on Aug 24, 2018 8:43am

54 Views

Post# 28510566

RE:RE:It’s a tie game

Y’all should have listened and flipped at .60 . You’d be up 60% in the last 2 weeks instead of riding this sinking ship.. ...

Crazyfrog1 wrote: And the winner is .... NDVA blowing past LDS. Hate to say I told you all ...

Crazyfrog1 wrote: NDVA vs LDS.
-47 million mkt cap vs 55 million mkt cap.
-High quality weed and oils with 40,000 sp ft production with crop already harvested vs 20,000 sq ft of empty space.
-chocolate edibles and infused THC and CBD sugar technology for sale when market allows vs a company continually looking for biomass try to produce oil and an imaginary strip.
- one company operating in a federally legal environment and the other illegally .
-one company with 30 million in their bank account the other with 2.5 million left
https://m.youtube.com/watch?v=G9t5hCSZ82c

https://www.indiva.com/

If you’re in the need for a smaller mj play in your portfolio then the choice is obvious.